Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2540761rdf:typepubmed:Citationlld:pubmed
pubmed-article:2540761lifeskim:mentionsumls-concept:C0027088lld:lifeskim
pubmed-article:2540761lifeskim:mentionsumls-concept:C0011106lld:lifeskim
pubmed-article:2540761lifeskim:mentionsumls-concept:C0030095lld:lifeskim
pubmed-article:2540761lifeskim:mentionsumls-concept:C0069841lld:lifeskim
pubmed-article:2540761lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:2540761pubmed:issue2lld:pubmed
pubmed-article:2540761pubmed:dateCreated1989-6-9lld:pubmed
pubmed-article:2540761pubmed:abstractTextTo investigate whether a putative oxytocin (OT) receptor blocker 1-deamino-[2-D-tyrosine (OEt)-4 threonine-8-ornithine]oxytocin (dTVT) inhibits OT binding to its receptors, we studied binding of [3H]OT to late-pregnant human, guinea pig, and rat myometrial and decidual membranes and competition of dTVT with this binding. Decidua as well as myometrium of all three species bound [3H]OT with high affinity (Kd 1-3 nM) and limited capacity. The concentration of binding sites in decidual membranes was slightly lower than in myometrial membranes in human and guinea pig uterus and twice that of myometrial membranes in day 20 pregnant rat uterus. dTVT competed with [3H]OT with highest affinity in guinea pig myomterium and decidua, the potency ratios ([dTVT]50: [OT]50) being 1.9 and 3.3, respectively. The potency ratios in rat uterine tissues and human decidua were slightly higher (4 to 5) and highest in human myometrium, 23.3. Excess dTVT completely inhibited [3H]OT binding in all six tissues, indicating binding to the same receptor sites. Because of the high-affinity binding of dTVT to oxytocin receptors in human decidua and myometrium, this oxytocin analogue may be a very effective tocolytic agent in the treatment of threatened preterm labor.lld:pubmed
pubmed-article:2540761pubmed:languageenglld:pubmed
pubmed-article:2540761pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2540761pubmed:citationSubsetIMlld:pubmed
pubmed-article:2540761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2540761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2540761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2540761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2540761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2540761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2540761pubmed:statusMEDLINElld:pubmed
pubmed-article:2540761pubmed:monthAprlld:pubmed
pubmed-article:2540761pubmed:issn0735-1631lld:pubmed
pubmed-article:2540761pubmed:authorpubmed-author:FuchsA RARlld:pubmed
pubmed-article:2540761pubmed:authorpubmed-author:VangstedAAlld:pubmed
pubmed-article:2540761pubmed:authorpubmed-author:IvanisevicMMlld:pubmed
pubmed-article:2540761pubmed:authorpubmed-author:DemarestKKlld:pubmed
pubmed-article:2540761pubmed:issnTypePrintlld:pubmed
pubmed-article:2540761pubmed:volume6lld:pubmed
pubmed-article:2540761pubmed:ownerNLMlld:pubmed
pubmed-article:2540761pubmed:authorsCompleteYlld:pubmed
pubmed-article:2540761pubmed:pagination205-8lld:pubmed
pubmed-article:2540761pubmed:dateRevised2008-9-3lld:pubmed
pubmed-article:2540761pubmed:meshHeadingpubmed-meshheading:2540761-...lld:pubmed
pubmed-article:2540761pubmed:meshHeadingpubmed-meshheading:2540761-...lld:pubmed
pubmed-article:2540761pubmed:meshHeadingpubmed-meshheading:2540761-...lld:pubmed
pubmed-article:2540761pubmed:meshHeadingpubmed-meshheading:2540761-...lld:pubmed
pubmed-article:2540761pubmed:meshHeadingpubmed-meshheading:2540761-...lld:pubmed
pubmed-article:2540761pubmed:meshHeadingpubmed-meshheading:2540761-...lld:pubmed
pubmed-article:2540761pubmed:meshHeadingpubmed-meshheading:2540761-...lld:pubmed
pubmed-article:2540761pubmed:meshHeadingpubmed-meshheading:2540761-...lld:pubmed
pubmed-article:2540761pubmed:meshHeadingpubmed-meshheading:2540761-...lld:pubmed
pubmed-article:2540761pubmed:meshHeadingpubmed-meshheading:2540761-...lld:pubmed
pubmed-article:2540761pubmed:meshHeadingpubmed-meshheading:2540761-...lld:pubmed
pubmed-article:2540761pubmed:meshHeadingpubmed-meshheading:2540761-...lld:pubmed
pubmed-article:2540761pubmed:meshHeadingpubmed-meshheading:2540761-...lld:pubmed
pubmed-article:2540761pubmed:meshHeadingpubmed-meshheading:2540761-...lld:pubmed
pubmed-article:2540761pubmed:year1989lld:pubmed
pubmed-article:2540761pubmed:articleTitleOxytocin antagonist (dTVT) and oxytocin receptors in myometrium and decidua.lld:pubmed
pubmed-article:2540761pubmed:affiliationDepartment of Obstetrics and Gynecology, Cornell University Medical College, New York, New York 10022.lld:pubmed
pubmed-article:2540761pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2540761pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2540761lld:pubmed